Because of the apparently essential function of CHK1 for cell survival [41], CHK1 inhibitors were widely explored for their potential cancer therapeutic effects as a monotherapy or in combination with other cancer drugs [35, 48–51]. This evidence concerns the gene CHEK1 and cancer.